Skip to main content
Fig. 7 | EJNMMI Radiopharmacy and Chemistry

Fig. 7

From: Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-11C]β-hydroxybutyrate ([11C]OHB) PET in healthy humans

Fig. 7

Whole-blood activity of [11C] as CO2 measured at 5 min (6.16 \(\pm \hspace{0.17em}\)5.46%), 10 min (12.99 \(\pm \hspace{0.17em}\)6.33%), 15 min (20.67 \(\pm \hspace{0.17em}\)8.73%), 20 min (25.10 \(\pm \hspace{0.17em}\)10.03%), 30 min (35.91 \(\pm \hspace{0.17em}\)15.48%), 50 min (47.97 \(\pm \hspace{0.17em}\)16.56%), 70 min (52.32 \(\pm \hspace{0.17em}\)14.78%) and 90 min (55.85 \(\pm \hspace{0.17em}\)11.90%). Values are mean \(\pm\) SEM

Back to article page